Othman, O. A. (2016). FK866 reduces axon pathology in in vitro and in vivo models of Huntington’s disease and Alzheimer’s disease and attenuates behavioral abnormalities.
Chicago Style (17th ed.) CitationOthman, Othman Ahmad. FK866 Reduces Axon Pathology in in Vitro and in Vivo Models of Huntington’s Disease and Alzheimer’s Disease and Attenuates Behavioral Abnormalities. 2016.
MLA (9th ed.) CitationOthman, Othman Ahmad. FK866 Reduces Axon Pathology in in Vitro and in Vivo Models of Huntington’s Disease and Alzheimer’s Disease and Attenuates Behavioral Abnormalities. 2016.
Warning: These citations may not always be 100% accurate.